Thymic function & adaptive immunity
The thymus trains T-cells, and it starts shrinking from puberty — by sixty it is mostly fat.
- Route1 of 5 to immune resilience
- Options13
Is this pathway actually your problem?
The lymphocyte count on a standard full blood count is a free read on adaptive immune capacity. Persistently low, with low zinc or vitamin D, is the most correctable part of immune ageing.
What engages this pathway
Ordered by how directly each one acts on the mechanism, never by how much trial evidence exists. Each opens its full breakdown.
Most options here use this code. Each Shop link copies its own as the store opens.
The free peptide field guide
The 12 compounds people ask about most: how each one works, what the research shows, the markers that say whether it is doing anything, and what most people get wrong.
After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.
How it works, in full
How this pathway works
The mechanism in full
The thymus trains T-cells, and it starts shrinking from puberty — by sixty it is mostly fat. That involution is one of the clearest, most measurable causes of immune ageing, and the peptide bioregulators in this pathway were built specifically for it.
What each option’s mechanism predicts here
13 predictions, in full
- Thymosin Alpha 1
A thymic peptide that promotes T-cell maturation and modulates dendritic-cell function. Approved in over 30 countries for hepatitis B and C and used as an adjuvant in sepsis and vaccination — the best-evidenced immune peptide available.
- Thymalin
A thymic peptide extract from Khavinson's Russian program, with reported long-term mortality benefit in elderly cohorts. The follow-up data is remarkable and independently unreplicated, which is the honest summary of the whole bioregulator class.
- Thymulin
The endogenous thymic hormone the extracts above are reaching for, with a catch that reframes the entry: it is inactive until zinc binds it. Thymulin activity falls with age and falls in zinc deficiency, and the two are hard to separate — so correcting zinc status may do part of the same job, measurably and for almost nothing. Read it alongside the zinc entry below, not instead of it.
- Thymogen
A synthetic dipeptide derived from thymalin's active fragment.
- Vladonix
Oral thymus bioregulator from the same series.
- Crystagen
Immune-system bioregulator peptide, same evidence caveat.
- Thymosin Beta-4
Distinct from alpha-1 — primarily a tissue-repair peptide with immunomodulatory activity as a secondary property.
- Zinc
Required for thymulin activity and T-cell function. Deficiency causes measurable thymic atrophy, and zinc status falls with age — this is the most correctable part of immune ageing.
- Vitamin D
T-cells require vitamin D signaling to activate. Meta-analysis shows supplementation reduces acute respiratory infection risk, with the effect concentrated in the deficient.
- Vitamin A
Required for T-cell differentiation and secretory IgA. Deficiency is a leading cause of childhood infectious mortality globally.
- Selenium
Deficiency impairs T-cell response and allows RNA viruses to mutate more rapidly in host tissue — a strange and well-documented finding.
- Glutathione
Lymphocytes need glutathione to proliferate; depletion directly limits the adaptive response.
- NAC
Glutathione precursor with trial evidence for reducing influenza symptom severity in older adults.
The deep read
What decides it, the order to test, what cannot move it
What actually decides this outcome, in order of size
The thymus is where T cells are selected, and it begins shrinking from puberty. That makes this one of the few aging processes with a known tissue, a known schedule and a specific pharmacology aimed at it. Ranked by how much of the outcome each factor owns:
- Age, which sets the size of the organ and is not negotiable. The mechanisms and functional impact of age-related thymic involution have been reviewed Liang 2022, and the somatotropic circuitry inside the thymus is itself part of the story Reis 2023. Nothing on the shelf reverses a schedule that began at puberty; the honest question is whether output can be nudged.
- WHETHER YOU CAN MEASURE THE THING THE PAGE IS ABOUT, which is the hinge and the answer is largely no. Measuring thymic output across the human lifespan has been described as a critical challenge in laboratory medicine Middelkamp 2025. A consumer can buy a lymphocyte count and a subset panel; the assay that would show new thymic emigrants is a research procedure. So this page's central claim is, for the reader, structurally unfalsifiable at home — and saying so is more useful than a proxy that does not mean what it looks like.
- DIRECTION, because more adaptive activity is not universally wanted. This is the page's sign problem. In an immunosenescent seventy-year-old, more T cell output is the goal. In somebody with autoimmune disease it is the opposite of the goal, and the largest randomized evidence on the immune side of the shelf ran the other way: a trial of vitamin D and marine omega-3 reported on incident autoimmune disease Hahn 2022, with outcomes reported two years after completion Costenbader 2024. Read those before assuming that boosting is the direction you want.
- Which peptide, because they are not one product. Thymosin alpha-1 has the largest clinical literature: a comprehensive review Dominari 2020, randomized work in severe sepsis Wu 2013, a systematic review in sepsis Liu 2016, a postoperative survival analysis in hepatocellular carcinoma Linye 2021 and a review of antiviral roles Tao 2023. Every one of those is in ill patients with a defined condition.
- Micronutrient status, which is the boring half and the half with the clearest deficiency correction. Zinc, selenium and vitamin A are required for lymphocyte function, and correcting a measured deficiency is a much stronger proposition than supplementing a replete adult.
- What is actually in a Russian-origin vial, which is a manufacturing question before it is a biological one. The dipeptide composition of thymalin has been analyzed Linkova 2023, and Thymosin Beta-4 — a different molecule entirely, an actin-binding peptide rather than a thymic hormone — has a first-in-human phase 1 program Wang 2021.
The order to run these in, and what has to be true first
Correct what can be measured, then decide whether the peptide argument applies to you at all, and be honest that the confirmation you would want does not exist at consumer level.
- Establish the direction before anything else. ANA (Antinuclear Antibodies) and Thyroid Antibodies (TPO + TgAb) if there is any autoimmune history, personal or family. This is the one page where the wrong answer to that question makes the whole shelf inadvisable rather than merely useless Hahn 2022.
- Baseline immune bloods, which are cheap and genuinely informative about the ordinary causes. Complete Blood Count (CBC) with Differential with differential, hs-CRP (High-Sensitivity C-Reactive Protein), Vitamin D (25-Hydroxy), Zinc, Plasma and Selenium, Blood. Frequent infections with a normal count and normal micronutrients is a different problem from frequent infections with a low lymphocyte count.
- Vitamin D, Zinc, Selenium and Vitamin A as corrections rather than as therapy. The randomized vitamin D data that exists on immune endpoints is about autoimmune incidence Hahn 2022 Costenbader 2024 rather than about resistance to colds, and that is the claim it supports.
- NAC and Glutathione are redox support and belong to the lymphocyte-function argument, not to the thymic-output one. They are on the page because glutathione status affects lymphocyte proliferation, which is a different mechanism from thymic education.
- Thymosin Alpha 1 is the item with real clinical trials, and the trials are in patients Dominari 2020 Wu 2013 Liu 2016 Linye 2021 Tao 2023. Extrapolating a sepsis or oncology result to a healthy adult wanting fewer winter colds is an extrapolation and is labeled as one here.
- Thymalin, Thymulin, Thymogen, Vladonix and Crystagen are the bioregulator arm. The dipeptide analysis is the most concrete thing published about what is in them Linkova 2023. What they are, how they were tested and what the regulatory category means is at Thymus & immune, which is the page for that argument.
- Thymosin Beta-4 is on this list by name rather than by biology. It is an actin-binding repair peptide with a phase 1 program Wang 2021; its home is Angiogenesis & cytoprotection, and the shared word 'thymosin' is a historical naming accident rather than a shared mechanism.
What gets bought for this that cannot move it
The category that fails structurally is the immune booster bought by somebody whose problem is an over-active immune system. The adaptive arm is the arm that attacks self tissue when it goes wrong, and the largest randomized data on this shelf measured incident autoimmune disease as its endpoint Hahn 2022 Costenbader 2024. A reader with thyroid antibodies, celiac disease, psoriasis or rheumatoid disease who buys a thymic peptide to stop catching colds is asking for more of the process that is already the problem. That is the sign failure on this page, and it belongs at the top of it rather than in a footnote.
The option whose prediction is weaker than its marketing is the thymic peptide bought by a healthy adult. The clinical evidence for Thymosin Alpha 1 is in sepsis, hepatitis and cancer populations Wu 2013 Liu 2016 Linye 2021, where the immune system is failing at a defined task under medical supervision. There is no trial of the same molecule in a well person seeking fewer infections. The mechanism is plausible in both settings; the effect size in the second is unmeasured, and the price is not.
And the read-out failure is unusually pure here. Thymic output is hard to measure even in laboratory medicine Middelkamp 2025. That means a reader cannot confirm target engagement, which in turn means the entire experience of the intervention is a season with fewer colds — an endpoint with enormous year-to-year variance and no control arm. Anybody selling a consumer test of thymic function is selling something the field itself describes as a challenge.
If the goal underneath is different, so is the page. If the problem is an over-active response, Autoimmunity & calming an over-active response. If it is getting through an infection that is already happening, Acute infection — antivirals & antimicrobials. If it is the first-line innate system, Innate immunity & trained immunity. If it is mucosal defense, Barrier & mucosal immunity. And recurrent serious infections, rather than frequent minor ones, is an immunology referral rather than a supplement decision.
How you would know it was working, on a real read-out and a real timescale
This page makes two predictions. A Complete Blood Count (CBC) with Differential with differential will explain more presentations than any peptide will change, because a low lymphocyte count has causes with treatments; and no product here will move a marker you can buy that specifically reflects thymic output, because that measurement is a research procedure Middelkamp 2025.
- Complete Blood Count (CBC) with Differential with differential at baseline and 12 weeks. Absolute lymphocyte count is the closest routinely available number to this page's subject, and it is a crude proxy rather than a thymic measurement; twelve weeks because lymphocyte populations shift slowly outside acute illness.
- Vitamin D (25-Hydroxy), Zinc, Plasma and Selenium, Blood at baseline and 12 weeks. These are the three correctable micronutrients with a defensible immune role, and the point of the recheck is to confirm repletion rather than to keep dosing indefinitely.
- hs-CRP (High-Sensitivity C-Reactive Protein) at baseline and 12 weeks. If something on this page is producing systemic immune activation, this is the cheapest place it would appear — and a rise is a reason to stop, not a sign of working.
- ANA (Antinuclear Antibodies) and Thyroid Antibodies (TPO + TgAb) once, before starting any peptide, if there is autoimmune history. These decide whether the direction of this page is right for you, which is a different question from whether the products work Hahn 2022.
- A written count of infection episodes and days unwell across a full twelve months, started before the first dose. Twelve months because respiratory infection is seasonal and any shorter window compares a summer with a winter.
What will fool you. A mild winter is the most common reason somebody concludes an immune product worked. A normal lymphocyte count does not exclude poor thymic output and a low one has many non-thymic causes Liang 2022. Trials in critically ill or oncology populations Wu 2013 Linye 2021 are routinely quoted as though they were healthy-adult prevention data. Thymosin Beta-4 is not a thymic hormone despite the name Wang 2021. And a peptide that arrives as a lyophilized powder with no certificate of analysis has an identity question in front of the efficacy question Linkova 2023.
Sources read for these sections
- Liang Z. Age-related thymic involution: Mechanisms and functional impact. Aging Cell 2022 · PMID 35822239
- Middelkamp V. Measuring thymic output across the human lifespan: a critical challenge in laboratory medicine. GeroScience 2025 · PMID 39946072
- Reis MDDS, et al. Intrathymic somatotropic circuitry: consequences upon thymus involution. Frontiers in Immunology 2023 · PMID 37426675
- Dominari A, et al. Thymosin alpha 1: A comprehensive review of the literature. World Journal of Virology 2020 · PMID 33362999
- Wu J, et al. The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial. Critical Care 2013 · PMID 23327199
- Liu F, et al. The efficacy of thymosin alpha1 as immunomodulatory treatment for sepsis: a systematic review of randomized controlled trials. BMC Infectious Diseases 2016 · PMID 27633969
- Linye H, et al. Thymosin alpha-1 therapy improves postoperative survival after curative resection for solitary hepatitis B virus-related hepatocellular carcinoma: A propensity score matching analysis. Medicine (Baltimore) 2021 · PMID 34011034
- Tao N, et al. Thymosin alpha1 and Its Role in Viral Infectious Diseases: The Mechanism and Clinical Application. Molecules 2023 · PMID 37110771
- Hahn J. Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ 2022 · PMID 35082139
- Costenbader KH. Vitamin D and Marine n-3 Fatty Acids for Autoimmune Disease Prevention: Outcomes Two Years After Completion of a Double-Blind, Placebo-Controlled Trial. Arthritis and Rheumatology 2024 · PMID 38272846
- Linkova N. The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19. International Journal of Molecular Sciences 2023 · PMID 37686182
- Wang X, et al. A first-in-human, randomized, double-blind, single- and multiple-dose, phase I study of recombinant human thymosin beta4 in healthy Chinese volunteers. Journal of Cellular and Molecular Medicine 2021 · PMID 34346165
The markers that test it
5 markers
Retest timing, taken from each marker’s own page. When to retest: Complete Blood Count (CBC) with Differential, 3 and 6 months after starting TRT, then every 6–12 months; Vitamin D (25-Hydroxy), 8–12 weeks after a dose change, then every 6–12 months; Zinc, RBC, 12 weeks after starting supplementation; Selenium, Blood, 12 weeks after supplementation; Vitamin A, 12 weeks after changing intake.
Where each one should sit, from the same pages: Vitamin D (25-Hydroxy), 40–60 ng/mL.
The other 4 routes to immune resilience
Pick the pathway that matches where you are actually stuck
How to read the evidence labels
Nothing here is ranked by tier
Nothing here is ranked by evidence tier. A lot of what works in this space has never had the trial run, and sorting by trial count would bury exactly the compounds you came looking for. The tier is a label. The mechanism is the map.
Of the 13 options on this page, 6 (46%) rest on human trials and 7 (54%) on mechanism and lab or animal work.
Questions people ask
4 answered
- What is the thymic function & adaptive immunity pathway for immune resilience?
- The thymus trains T-cells, and it starts shrinking from puberty — by sixty it is mostly fat. That involution is one of the clearest, most measurable causes of immune ageing, and the peptide bioregulators in this pathway were built specifically for it.
- What compounds and supplements work through thymic function & adaptive immunity?
- 13 options are mapped to this pathway in the Vault, including Thymosin Alpha 1, Thymalin, Thymulin, Thymogen. They are grouped by the mechanism they act through rather than ranked by how much trial evidence exists — 6 carry clinical validation and 7 are mechanistic predictions.
- How do I know if thymic function & adaptive immunity is actually my problem?
- The lymphocyte count on a standard full blood count is a free read on adaptive immune capacity. Persistently low, with low zinc or vitamin D, is the most correctable part of immune ageing. The markers worth checking are Complete Blood Count (CBC) with Differential, Vitamin D (25-Hydroxy), Zinc, RBC, Selenium, Blood.
- Are the 7 theoretical options for thymic function & adaptive immunity worth considering?
- Unproven is not the same as ineffective. Of the 13 options on this pathway, 6 have clinical validation and 7 are graded theoretical — meaning the mechanism is sound but the specific human trial has not been run, which is true of a great deal of what works in this space. Nothing on this page is ordered by evidence tier, because sorting by trial count would bury the compounds you came looking for.
The Immune resilience Blueprint is in Skool
This pathway is one arm of The Immune resilience Blueprint. The members’ version has where this arm sits in the sequence, what to stack it with, and the markers that tell you to keep going or stop.
- Where each pathway sits in the sequence, and what runs first
- What stacks with what, and what never overlaps
- The markers that tell you to keep going or stop
5.0 (15 reviews)1,500+ members

Want it built around you?

1-on-1 coaching
Cam and Coach Reece build training, nutrition, protocol and bloodwork around you. It starts with a free call.
from $150/mo
Apply for coaching
Ask Cam one question
Fifteen minutes on one topic, usually enough to settle which option is yours.
$75 per call
Book 15 minutesThe blueprint this pathway sits inside
Educational and research reference only — not medical advice, and not a recommendation for human use. Mechanistic predictions are exactly that: what the biology suggests should happen, which is not the same as what has been shown to happen. Some links are affiliate links. Medical disclaimer and affiliate disclosure